ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,750Medicare Part D Prescriptions Filled, Including Refills

Rank: 19 out of 546

$814K Total Retail Price of All Prescriptions

Rank: 8 out of 546

667 Patients Receiving at Least One Drug in Part D
79%Patients 65 Years and Older
76% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Maine
Lower avg

Schedule Two
Controlled Substances

9% of this provider’s 667 patients filled at least one prescription for a schedule two drug, compared to an average of 9%.

Schedule Three
Controlled Substances

10% of this provider’s 667 patients filled at least one prescription for a schedule three drug, compared to an average of 10%.

Risky Drugs to Seniors

4% of this provider’s 9,923 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

21% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$69 was the average price of a prescription from this provider, compared to $65 among peers.

Prescriptions per Patient

18 is the average number of prescriptions (including refills) per patient, compared to an average of 17.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Maine
LISINOPRIL 499 420 1 1
SIMVASTATIN 493 404 2 2
METOPROLOL TARTRATE 429 377 3 6
LEVOTHYROXINE SODIUM 398 363 4 3
OMEPRAZOLE 310 260 5 4
SERTRALINE HCL 293 231 6 14
FUROSEMIDE 258 240 7 5
ATENOLOL 244 228 8 12
AMLODIPINE BESYLATE 229 206 9 9
ATORVASTATIN CALCIUM 199 186 10 11
METFORMIN HCL 187 148 11 10
GABAPENTIN 183 153 12 16
GLYBURIDE 169 155 R 13 45
PAROXETINE HCL 161 98 14 43
HYDROCODONE-ACETAMINOPHEN 144 107 S3 15 8
WARFARIN SODIUM 141 117 16 13
ZOLPIDEM TARTRATE 140 126 17 26
DONEPEZIL HCL 140 128 17 31
ISOSORBIDE MONONITRATE ER 132 115 19 32
HYDROCHLOROTHIAZIDE 125 101 20 7
PRAVASTATIN SODIUM 122 109 21 33
RANITIDINE HCL 120 98 22 23
PANTOPRAZOLE SODIUM 116 97 23 18
TAMSULOSIN HCL 104 92 24 35
KLOR-CON M20 98 88 25 57
MELOXICAM 93 86 26 58
LANTUS 90 71 27 46
POTASSIUM CHLORIDE 89 78 28 30
FENTANYL 88 85 S2 29 50
ALLOPURINOL 87 81 30 41
METOPROLOL SUCCINATE 87 78 30 17
TRAZODONE HCL 86 67 32 25
PREDNISONE 84 64 33 29
DOXYCYCLINE HYCLATE 81 72 34 144
ADVAIR DISKUS 80 71 35 20
CIPROFLOXACIN HCL 80 75 35 84
AMOX TR-POTASSIUM CLAVULANATE 80 66 35 154
AMITRIPTYLINE HCL 77 74 R 38 48
TRAMADOL HCL 76 43 39 19
DIOVAN 75 67 40 65
NAMENDA 72 61 41 60
NEXIUM 72 64 41 52
FLUTICASONE PROPIONATE 72 55 41 42
ZETIA 70 54 44 81
LISINOPRIL-HYDROCHLOROTHIAZIDE 66 56 45 49
LOVASTATIN 65 60 46 22
DOXAZOSIN MESYLATE 65 50 46 98
JANTOVEN 63 49 48 92
LOSARTAN POTASSIUM 60 52 49 24
BACLOFEN 60 34 49 86
CRESTOR 57 54 51 36
CITALOPRAM HBR 56 44 52 21
DILTIAZEM 24HR CD 55 36 53 91
ALENDRONATE SODIUM 53 53 54 38
CLOPIDOGREL 52 49 55 77
NYSTATIN 52 48 55 97
CYCLOBENZAPRINE HCL 51 39 R 57 34
ZOSTAVAX 51 46 57 164
LEVETIRACETAM 51 51 57 95
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Feb. 5, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.